DE602008003411D1 - Verwendung von d-ribose zur behandlung von vorhofflimmern - Google Patents

Verwendung von d-ribose zur behandlung von vorhofflimmern

Info

Publication number
DE602008003411D1
DE602008003411D1 DE602008003411T DE602008003411T DE602008003411D1 DE 602008003411 D1 DE602008003411 D1 DE 602008003411D1 DE 602008003411 T DE602008003411 T DE 602008003411T DE 602008003411 T DE602008003411 T DE 602008003411T DE 602008003411 D1 DE602008003411 D1 DE 602008003411D1
Authority
DE
Germany
Prior art keywords
ribose
liabilities
previous
treatment
atrial fibrillation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602008003411T
Other languages
German (de)
English (en)
Inventor
James D Herrick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bioenergy Inc
Original Assignee
Bioenergy Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioenergy Inc filed Critical Bioenergy Inc
Publication of DE602008003411D1 publication Critical patent/DE602008003411D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DE602008003411T 2007-01-23 2008-01-23 Verwendung von d-ribose zur behandlung von vorhofflimmern Active DE602008003411D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88194007P 2007-01-23 2007-01-23
PCT/US2008/000845 WO2008091618A1 (en) 2007-01-23 2008-01-23 Use of d-ribose to treat cardiac arrhythmias

Publications (1)

Publication Number Publication Date
DE602008003411D1 true DE602008003411D1 (de) 2010-12-23

Family

ID=39264528

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602008003411T Active DE602008003411D1 (de) 2007-01-23 2008-01-23 Verwendung von d-ribose zur behandlung von vorhofflimmern

Country Status (10)

Country Link
US (1) US8101581B2 (https=)
EP (1) EP2120968B1 (https=)
JP (1) JP5396387B2 (https=)
CN (1) CN101588807B (https=)
AT (1) ATE487485T1 (https=)
BR (1) BRPI0806231A2 (https=)
CA (1) CA2674717C (https=)
DE (1) DE602008003411D1 (https=)
ES (1) ES2352154T3 (https=)
WO (1) WO2008091618A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020119933A1 (en) * 2000-07-28 2002-08-29 Butler Terri L. Compositions and methods for improving cardiovascular function
US8101581B2 (en) 2007-01-23 2012-01-24 Bioenergy, Inc. Use of D-ribose to treat cardiac arrhythmias
CN106138071A (zh) * 2008-04-02 2016-11-23 生物能公司 核糖在对于急性心肌梗塞的第一反应中的用途
EP3411041A1 (en) 2016-02-01 2018-12-12 RiboCor, Inc. Use of ribose for treatment of subjects having congestive heart failure

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4605644A (en) * 1985-02-07 1986-08-12 Regents Of The University Of Minnesota Method for stimulating recovery from ischemia employing ribose and adenine
US4719201A (en) * 1985-02-07 1988-01-12 Regents Of The University Of Minnesota Method for stimulating recovery from ischemia
US4824660A (en) * 1985-06-06 1989-04-25 Paul S. Angello Method of determining the viability of tissue in an organism
DE4228215A1 (de) 1992-08-25 1994-03-03 Pliml Wolfgang Verwendung von Ribose zur Herstellung eines Arzneimittels zur Behandlung von Leistungsschwächen des Körpers, insbesondere von Organinsuffizienzen
RU2127548C1 (ru) * 1996-06-26 1999-03-20 Алабовский Владимир Владимирович Способ коронарографии в эксперименте
DE19650754A1 (de) * 1996-12-06 1998-06-10 Wolfgang Dr Pliml Ribose und Schlaganfall
US6159942A (en) * 1998-06-19 2000-12-12 Bioenergy, Inc. Compositions for increasing energy in vivo
US6218366B1 (en) * 1998-06-19 2001-04-17 Bioenergy, Inc. Method for raising the hypoxic threshold
US6429198B1 (en) * 1999-04-12 2002-08-06 Bioenergy Inc. Compositions for increasing athletic performance in mammals
US20020119933A1 (en) * 2000-07-28 2002-08-29 Butler Terri L. Compositions and methods for improving cardiovascular function
US6534480B2 (en) * 1999-06-17 2003-03-18 Bioenergy Inc. Compositions for increasing energy in vivo
US6339716B1 (en) * 1999-09-24 2002-01-15 Bioenergy Inc. Method for determining viability of a myocardial segment
US6511964B2 (en) * 1999-09-24 2003-01-28 Bioenergy, Inc. Method for treating acute mountain sickness
US6159943A (en) * 1999-09-24 2000-12-12 Bioenergy, Inc. Use of ribose to prevent cramping and soreness in muscles
US6703370B1 (en) * 1999-10-27 2004-03-09 Bioenergy, Inc. Use of ribose to treat fibromyalgia
DE10085291T1 (de) * 1999-12-21 2003-05-08 Bioenergy Inc Zusammensetzungen für die Lagerung von Blutplättchen
EP1282424A1 (en) * 2000-01-07 2003-02-12 Bioenergy Inc. compositions for enhancing the immune response
AU2001229672A1 (en) * 2000-01-20 2001-07-31 Bioenergy Inc. Use of ribose supplementation for increasing muscle mass and decreasing body fatin humans
US6420342B1 (en) * 2000-05-08 2002-07-16 N.V. Nutricia Nutritional preparation comprising ribose and medical use thereof
IT1317043B1 (it) * 2000-06-14 2003-05-26 Sigma Tau Healthscience Spa Integratore alimentare potenziante il metabolismo energeticomuscolare, comprendente una alcanoil l-carnitina e ribosio.
US20030212006A1 (en) * 2002-05-13 2003-11-13 Seifert John G. Method for reducing free radical formation in healthy individuals undergoing hypoxic exercise and medical conditions with increased oxygen free radicals
US8486859B2 (en) * 2002-05-15 2013-07-16 Bioenergy, Inc. Use of ribose to enhance plant growth
US8759315B2 (en) * 2003-05-14 2014-06-24 Viacell, Llc Methods for rejuvenating
US7687468B2 (en) * 2003-05-14 2010-03-30 Viacell, LLC. Rejuvenation of stored blood
US20040229205A1 (en) * 2003-05-16 2004-11-18 Ericson Daniel G. Compositions for the storage of platelets
EP1703913B1 (en) * 2004-01-14 2012-08-01 RiboCor, Inc. Use of ribose in recovery from anaesthesia
US20050277598A1 (en) * 2004-04-29 2005-12-15 Maccarter Dean J Method for improving ventilatory efficiency
US20100099630A1 (en) * 2004-04-29 2010-04-22 Maccarter Dean J Method for improving ventilatory efficiency
EP1800675B1 (en) * 2005-12-23 2011-05-18 N.V. Nutricia Composition comprising polyunsaturated fatty acids, proteins, manganese and/or molybden and nucleosides/nucleotides for treating dementia
US8835396B2 (en) * 2006-12-15 2014-09-16 Bioenergy, Inc. Method and compositions for improving pulmonary hypertension
US8101581B2 (en) 2007-01-23 2012-01-24 Bioenergy, Inc. Use of D-ribose to treat cardiac arrhythmias
US20080312169A1 (en) * 2007-03-20 2008-12-18 Clarence Albert Johnson Cosmetic use of D-ribose
US20090197819A1 (en) * 2007-03-20 2009-08-06 Clarence Albert Johnson Compositions for improving and repairing skin
US20090232750A1 (en) * 2008-03-13 2009-09-17 St Cyr John A Compositions for indoor tanning
CN106138071A (zh) * 2008-04-02 2016-11-23 生物能公司 核糖在对于急性心肌梗塞的第一反应中的用途
US20090286750A1 (en) * 2008-05-16 2009-11-19 Kasubick Robert V Use of ribose in lessening the clinical symptoms of aberrant firing of neurons

Also Published As

Publication number Publication date
EP2120968A1 (en) 2009-11-25
WO2008091618A8 (en) 2010-04-01
JP2010526884A (ja) 2010-08-05
ES2352154T3 (es) 2011-02-16
US8101581B2 (en) 2012-01-24
CA2674717C (en) 2015-10-13
ATE487485T1 (de) 2010-11-15
CN101588807B (zh) 2012-07-04
WO2008091618A1 (en) 2008-07-31
EP2120968B1 (en) 2010-11-10
BRPI0806231A2 (pt) 2011-09-06
US20080176809A1 (en) 2008-07-24
CN101588807A (zh) 2009-11-25
JP5396387B2 (ja) 2014-01-22
CA2674717A1 (en) 2008-07-31

Similar Documents

Publication Publication Date Title
EA201100564A1 (ru) Антипролиферативные соединения
ECSP10010310A (es) Nuevos compuestos y composiciones y métodos de uso
TN2010000137A1 (en) Spiropyrrolidines and their use against hcv and hiv infection
EA200801717A1 (ru) Композиция местного применения по уходу за кожей, продукт на ее основе и способ лечения
EA201270803A1 (ru) Тиоацетатные соединения, композиции на их основе и способы их применения
EA200800172A1 (ru) 2,4-диаминопиримидины как ингибиторы aurora
ATE489957T1 (de) Mittel zur behandlung von entzündlichen erkrankungen
EP2494059A4 (en) USE OF METHYLSULFONYLMETHANE (MSM) TO MODULATE MICROBIAL ACTIVITY
EA201190217A1 (ru) Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение
MY170728A (en) Treatment for diabetes in patients inappropriate for metformin therapy
EA200870019A1 (ru) Лактамовые соединения и способы их применения
TW200637522A (en) Skin treatment articles and methods
WO2009044173A3 (en) Methods of treating cancer using notch pathway inhibitors
EA201000105A1 (ru) Химические соединения
MX2010003258A (es) Utilizacion de un nuevo agente natural en composiciones cosmeticas.
EA202091999A3 (ru) Применение ингибиторов dpp iv
NO20065847L (no) Difenylimidazopyrimidiner og -imidazolaminer som inhibitorer av B-sekretase
EA201100505A1 (ru) Органические соединения для применения для лечения бактериальных инфекций
TN2011000482A1 (en) Organic compounds and their uses
EA201000098A1 (ru) Производные хиназолинамида
EA200802223A1 (ru) 1,5-дифенилпиразолы ii в качестве ингибиторов hsp90
EA200802329A1 (ru) Производные триазола ii
CL2011000798A1 (es) Uso de etexilato de dabigatran o una sal del mismo para preparar un medicamento util para la prevencion del ictus en pacientes que padecen fibrilacion auricular.
UY31305A1 (es) Derivados de 1,2,4,5-tetrahidro-3h-benzazepinas, su procedimiento de preparacion y las composiciones farmacéuticas que las contienen.
NO20084749L (no) Organiske forbindelser og deres anvendelser